Gupta N, Hu L J, Deen D F
Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco 94143-0520, USA.
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):885-95. doi: 10.1016/s0360-3016(96)00535-4.
This study aimed to determine the extent of paclitaxel-induced cytotoxicity and cell-cycle perturbations when used alone and in combination with radiation in human glioma cells.
The effect of paclitaxel alone on three human glioma cells lines--SF-126, U-87 MG, and U-251 MG--was assessed after 24, 48, 72, or 96 h treatment. For experiments in combination with radiation, cells were exposed to either a long (48-h) or short (8-h) duration of paclitaxel treatment prior to irradiation. Cell survival was determined by clonogenic assay. Cell cycle perturbations were assessed by using flow cytometry to measure the proportion of cells in G1, S, and G2/M phases.
When cells were treated with paclitaxel alone for > or = 24 h, cytotoxicity increased up to a threshold dose, after which it plateaued. When treatment duration was < or = 24 h, cytotoxicity was appreciably greater in U-251 MG cells than in SF-126 and U-87 MG cells. After 24 h of paclitaxel treatment, cells in plateau phase growth had increased survival compared to cells in log phase growth. In contrast, after 8 h paclitaxel treatment, mitotic cells had reduced survival compared to cells from an asynchronous population. Cell-cycle perturbations were consistent with the presence of a mitotic block after paclitaxel treatment, although changes in other cell-cycle phase fractions varied among cell lines. For experiments in combination with radiation, cytotoxicity was increased when cells were irradiated after 48 h of paclitaxel treatment but not after 8 h of treatment.
The duration of paclitaxel treatment and the location of cells in the cell cycle modify the degree of radiation cytotoxicity. The mechanisms of paclitaxel cytotoxicity are likely to be multifactorial because varying effects are seen in different cell lines. Furthermore, it is clear that simply increasing the number of cells in G2/M is insufficient in itself to increase the response of cells to radiation.
本研究旨在确定单独使用紫杉醇以及与放疗联合使用时,其对人胶质瘤细胞的细胞毒性程度和细胞周期扰动情况。
在处理24、48、72或96小时后,评估单独使用紫杉醇对三种人胶质瘤细胞系——SF - 126、U - 87 MG和U - 251 MG——的影响。对于联合放疗的实验,在照射前,细胞先接受长时间(48小时)或短时间(8小时)的紫杉醇处理。通过克隆形成试验确定细胞存活率。使用流式细胞术评估细胞周期扰动,以测量处于G1、S和G2/M期的细胞比例。
当细胞单独用紫杉醇处理≥24小时时,细胞毒性增加至阈值剂量,之后趋于平稳。当处理时间≤24小时时,U - 251 MG细胞中的细胞毒性明显大于SF - 126和U - 87 MG细胞。紫杉醇处理24小时后,处于平台期生长的细胞比对数期生长的细胞存活率更高。相反,紫杉醇处理8小时后,有丝分裂细胞比来自非同步群体的细胞存活率更低。细胞周期扰动与紫杉醇处理后有丝分裂阻滞的存在一致,尽管其他细胞周期阶段分数的变化在不同细胞系中有所不同。对于联合放疗的实验,当细胞在紫杉醇处理48小时后照射时,细胞毒性增加,但在处理8小时后照射则不然。
紫杉醇处理的持续时间以及细胞在细胞周期中的位置会改变放疗细胞毒性的程度。紫杉醇细胞毒性的机制可能是多因素的,因为在不同细胞系中观察到不同的效应。此外,很明显,仅仅增加处于G2/M期的细胞数量本身不足以增加细胞对放疗的反应。